This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Oct;132(4):1412.

doi: 10.1378/chest.07-0172.

Iseganan failure due to the wrong pharmaceutical technology

Hendrik van Saene, Joris van Saene, Luciano Silvestri, Miguel de la Cal, Richard Sarginson, Durk Zandstra

PMID: 17934138
DOI: 10.1378/chest.07-0172

Comment

Iseganan failure due to the wrong pharmaceutical technology

Hendrik van Saene et al. Chest. 2007 Oct.

. 2007 Oct;132(4):1412.

doi: 10.1378/chest.07-0172.

Authors

Hendrik van Saene, Joris van Saene, Luciano Silvestri, Miguel de la Cal, Richard Sarginson, Durk Zandstra

PMID: 17934138
DOI: 10.1378/chest.07-0172

No abstract available

PubMed Disclaimer

Comment on

Preventing ventilator-associated pneumonia in adults: sowing seeds of change.
Craven DE. Craven DE. Chest. 2006 Jul;130(1):251-60. doi: 10.1378/chest.130.1.251. Chest. 2006. PMID: 16840410 Review.

Similar articles

A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.
Kollef M, Pittet D, Sánchez García M, Chastre J, Fagon JY, Bonten M, Hyzy R, Fleming TR, Fuchs H, Bellm L, Mercat A, Mañez R, Martínez A, Eggimann P, Daguerre M, Luyt CE; Prevention of Pneumonia Study (POPS-1) Trial Group. Kollef M, et al. Am J Respir Crit Care Med. 2006 Jan 1;173(1):91-7. doi: 10.1164/rccm.200504-656OC. Epub 2005 Sep 28. Am J Respir Crit Care Med. 2006. PMID: 16192451 Clinical Trial.
Tigecycline for treating ventilator-associated pneumonia: a practical perspective.
Curcio D. Curcio D. Diagn Microbiol Infect Dis. 2011 Apr;69(4):466-7. doi: 10.1016/j.diagmicrobio.2010.11.001. Diagn Microbiol Infect Dis. 2011. PMID: 21396549 No abstract available.
Which is the right antibiotic treatment for ventilator-associated pneumonia?
Corona A. Corona A. Crit Care Med. 2007 Jul;35(7):1808; author reply 1808-9. doi: 10.1097/01.CCM.0000269403.20283.10. Crit Care Med. 2007. PMID: 17581392 No abstract available.
Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumonia.
Chastre J, Luyt CE. Chastre J, et al. Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S54-8. doi: 10.1086/653050. Clin Infect Dis. 2010. PMID: 20597673 Review.
Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia.
Kollef MH. Kollef MH. Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S29-35. doi: 10.1086/653037. Clin Infect Dis. 2010. PMID: 20597668 Review.

See all similar articles

Cited by

Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients.
Garbacz K, Kamysz W, Piechowicz L. Garbacz K, et al. Virulence. 2017 Jan 2;8(1):94-100. doi: 10.1080/21505594.2016.1213475. Epub 2016 Jul 22. Virulence. 2017. PMID: 27450039 Free PMC article. No abstract available.
Short antimicrobial peptides as cosmetic ingredients to deter dermatological pathogens.
Rahnamaeian M, Vilcinskas A. Rahnamaeian M, et al. Appl Microbiol Biotechnol. 2015 Nov;99(21):8847-55. doi: 10.1007/s00253-015-6926-1. Epub 2015 Aug 26. Appl Microbiol Biotechnol. 2015. PMID: 26307444 Free PMC article. Review.
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response.
Mercer DK, O'Neil DA. Mercer DK, et al. Front Immunol. 2020 Sep 17;11:2177. doi: 10.3389/fimmu.2020.02177. eCollection 2020. Front Immunol. 2020. PMID: 33072081 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.